Vaccine manufacturing doesn’t come cheap. It depends heavily on support from developed countries. It also requires much more than relaxing intellectual property rights and a desire for vaccine equity.
If universities produce graduates who can work effectively in a team, the healthcare system will be strengthened and this would improve the health outcomes for patients.
The strong disapproval of the South African government’s handling of the pandemic is a warning that crafting persuasive pro-vaccine messages is not enough.
Relying on donor funding means that the funder ultimately determines the health priorities. This is one reason why many programmes in Africa focus on a single disease such as HIV.
The rule, which previously acted as the upper time limit on human embryo research, has been dropped, paving the way for research on older human embryos.
National policies must incorporate good practices derived from lessons learnt so far to strengthen their health systems. Critical policy elements include preparedness and response.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand